Greenowl CBD

In 2026, GreenOwl CBD establishes itself as a key player in the wellness hemp market in France. Founded in Toulouse in 2018, the brand continues to offer products compliant with French regulations while informing its users about legal and scientific developments concerning cannabidiol. Through its articles, commitments, and products, GreenOwl meets a growing demand for natural alternatives for sleep, stress, and sports recovery.

Articles and guides published in 2026 on GreenOwl CBD

A comprehensive guide on the “Novel Food” status of CBD

On February 11, 2026, GreenOwl published an in-depth article on the “Novel Food” status of CBD, a concept still unclear to many. This status, defined by the European Union, classifies CBD as a novel food, implying strict conditions for its marketing. In 2026, CBD is still not authorized as a Novel Food in the EU. The EFSA (European Food Safety Authority) has set a provisional safe dose at 0.0275 mg/kg of body weight.

In this article, GreenOwl explains how its products (flowers, oils) comply with current French legislation, particularly with a THC level < 0.3%, while ensuring strict traceability. The potential benefits of CBD are also discussed, notably via PPARγ and GPR55 receptors, which could play a role in regulating metabolism and inflammation.

CBD in children: a sensitive topic

On February 4, 2026, another article published by GreenOwl addresses a frequently asked question: “Can you give CBD to your child?” The answer is clear: no, unless medically advised. The only authorized product for children in Europe remains Epidyolex®, prescribed for severe cases of epilepsy. The article warns against self-medication and reminds that even CBD-based products must be handled with caution in younger individuals.

Agenda of CBD events in 2026

GreenOwl also published a list of CBD-related events planned for 2026, with a focus on the Cannabis Europa fair, which will be held in Paris on February 19. The article provides practical advice for industry professionals and enthusiasts, particularly on early registration and trends to follow.

Problems GreenOwl CBD solves in 2026

Complex but legally circumvented legislation

The main challenge for the CBD market in 2026 remains legal uncertainty, particularly around Novel Food status and THC thresholds. Thanks to constant regulatory monitoring, GreenOwl offers legal products in France, respecting the 0.3% THC threshold, established since 2021 and confirmed in 2026. This compliance allows for the free circulation of CBD within the European Union, while avoiding legal risks related to the Kanavape ruling, extensively analyzed in this blog article.

Traceability, security, and transparency

GreenOwl emphasizes transparency: each product is laboratory analyzed, with certificates of analysis available. This reassures consumers about the quality, purity, and legality of the oils and flowers offered.

Concrete benefits for users in 2026

Athletes and recovery

More and more athletes, especially trail runners, use CBD to relieve post-exertion pain, improve sleep quality, or manage stress. GreenOwl offers products adapted to these needs, as evidenced by this article on CBD for trail runners.

Stress, sleep, and chronic pain

Regular users report reduced anxiety, improved sleep, and relief from chronic pain. Although studies are still limited, the anxiolytic effects of CBD are increasingly documented, particularly for social phobia or sleep disorders.

A legal and accessible solution

GreenOwl products comply with French and European legislation: non-narcotic, THC content < 0.3%, and free circulation in the EU. This ensures serene consumption, without legal risk.

Use cases and recent practical examples

For trail runners

CBD is used to improve post-exertion comfort, without replacing the importance of rest, nutrition, or hydration. Sublingual oils and vaporizable flowers are the most popular products among this community.

For children (with caution)

Only Epidyolex® is authorized for children suffering from severe epilepsy. GreenOwl reminds that no other CBD product should be administered to a minor without medical advice. The founders' personal story, facing Lyme disease, is evoked to illustrate the importance of adapted medical support.

In daily life

GreenOwl offers over 49 varieties of flowers and 14 oils, with weekly promotions to allow for an accessible introduction. These products are used to relieve everyday ailments, from stress to muscle pain.

Statistics and key market figures in 2026

0.0275 mg/kg: provisional safe dose set by EFSA for CBD.
0.3%: legal THC threshold in France and the EU.
+49 flower varieties, +14 oils, +39/+53/+43 other products available at GreenOwl.
10% of French adults consumed CBD in 2022 (figure still used in 2026).

Frequently asked questions in February 2026

Can you give CBD to your child?

No, unless medically advised. Only Epidyolex® is authorized for severe epilepsy cases in children. See the full article here.

Is CBD legal in France in 2026?

Yes, if the product contains less than 0.3% THC, is not a narcotic, and complies with French standards. More information in this detailed article.

What is "Novel Food" status?

CBD is considered a novel food in Europe, but it is not yet authorized. GreenOwl complies with the provisional safe dose set by EFSA. To learn more, consult this Chanvrery article.

News and trends from February 5-12, 2026

Publication of the Novel Food guide

On February 11, GreenOwl published a detailed article on Novel Food status, accompanied by promotional offers on flowers and oils. The goal is to reassure consumers about the legality and quality of the products.

Upcoming event: Cannabis Europa

The Cannabis Europa fair will be held in Paris on February 19. GreenOwl recommends that professionals and enthusiasts register quickly to not miss key conferences and meetings in the sector.

Trend of the week: regulatory vigilance

With the confirmation of the 0.3% THC threshold and the debates surrounding Kanavape, GreenOwl remains constantly vigilant to anticipate legal developments and adapt its products accordingly.

In February 2026, CBD consumers in France are more curious than ever about the legality, safety, and effectiveness of products offered by GreenOwl. Between European regulatory changes, unexpected customs seizures, and persistent misunderstandings about CBD flowers, it becomes essential to take stock. This article provides clear, documented, and practical answers to the most frequently asked questions about GreenOwl CBD, while guiding you in your choices with useful links and concrete advice.

Is it legal and safe to buy CBD from GreenOwl in 2026?

The legality of CBD sold by GreenOwl is based on a fundamental criterion: a THC content below 0.3%, in accordance with current European regulations. All products marketed by the brand comply with this limit, making them legal in France.

But despite this compliance, random customs seizures continue to occur. This may seem paradoxical, but these incidents are often linked to a lack of knowledge or inconsistent application of rules by certain customs authorities. For customers, this creates a form of uncertainty.

To learn more about current legislation, you can consult this detailed article on European CBD regulations.

Does GreenOwl comply with safety standards?

Yes. All products are laboratory tested, with certificates of analysis available on the product pages. These tests guarantee the absence of harmful contaminants (pesticides, heavy metals, residual solvents) and verify the exact CBD and THC levels.

What is the difference between CBD flowers and recreational cannabis?

Confusion persists among many beginners: visually, a CBD flower is remarkably similar to a classic cannabis flower. However, their chemical composition is radically different.

CBD flower contains a high concentration of cannabidiol (CBD), a non-psychoactive cannabinoid, and a THC level below 0.3%, which prevents any intoxicating effect. In contrast, recreational cannabis contains high levels of THC, a psychoactive substance responsible for euphoria and addiction.

To discover the varieties offered by GreenOwl, visit their selection of CBD flowers.

Can CBD be given to a child?

The answer is clear: no, unless medically prescribed. In February 2026, the European Food Safety Agency (EFSA) reiterated that CBD is not authorized as food for children. The only CBD-based product approved for pediatric use is Epidyolex, a prescription medication for certain rare forms of epilepsy.

GreenOwl strictly advises against the use of its products in minors without medical advice. For more information, consult their dedicated article: Can you give CBD to your child?

What is the status of CBD and Novel Food in 2026?

The status of CBD as Novel Food remains unclear in February 2026. In theory, any product containing extracted CBD must obtain specific authorization to be marketed as food in Europe. However, to date, no authorization has been officially issued.

The EFSA has set a safe daily dose at 0.0275 mg/kg of body weight. But this recommendation has not yet been translated into binding regulation. In the meantime, brands like GreenOwl circumvent this uncertainty by classifying their oils as wellness products, not intended for food.

To delve deeper into this topic, you can read this article on the legalization of CBD in France.

What problems are GreenOwl CBD users looking to solve?

Tension, stress, chronic pain

Customers primarily seek natural relief. Whether it's to soothe muscle tension, reduce anxiety, or improve sleep quality, GreenOwl products are perceived as a gentle and non-addictive alternative.

Full spectrum oils, in particular, are popular for their entourage effect, a phenomenon where different cannabinoids work in synergy. Discover their range on this page dedicated to full spectrum oils.

Anxiety attacks and sleep disorders

CBD acts as an indirect modulator of the endocannabinoid system. It helps regulate mood, the sleep-wake cycle, and stress responses. Users report faster sleep onset and deeper sleep, with no noticeable side effects.

Legal concerns

Despite the legality of the products, customers remain concerned about customs seizures. GreenOwl is actively working to secure its shipments and informs its customers via its official FAQ.

What do consumers do after obtaining the information?

Online purchase with fast delivery (often within 24 hours) and free shipping for orders over €50
Systematic verification of laboratory certificates
Visit to physical stores (9 in France) or call to customer service for personalized advice

What are the most frequent doubts and objections in February 2026?

Vague legislation

The main obstacle remains legal complexity. Even if CBD is legal, the vagueness surrounding Novel Food and occasional seizures create mistrust. GreenOwl addresses these concerns via its blog dedicated to legislation.

Safety for children

As mentioned above, the use of CBD in minors is strongly discouraged without a prescription. Parents must be vigilant.

Effectiveness and quality

Some users question the actual effectiveness of the products. The difference between full spectrum and broad spectrum oils, as well as oil preservation (avoiding oxidation), are points to clarify. GreenOwl provides all this information on its product pages.

The quality of the flowers is also a key topic: indoor cultivation, natural aromas, absence of contaminants. Certificates are available online for each batch.

What is the user level in 2026?

The majority of customers are beginners. They are looking to try CBD without breaking the bank. For this, GreenOwl offers trim buds at a reduced price and low-dose oils (5 to 10%), ideal for a gentle start.

New concerns since November 2025

Novel Food status still unclear
CBD in children: reinforced recommendations
Circulation of CBD in the European Union: legal, but under surveillance